References
- de Las HN, Ruiz-Ortega M, Ruperez M, et al. Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II. J Renin Angiotensin Aldosterone Syst. 2006;7(4):192–200
- Rodriguez-Iturbe B. Arteriolar remodeling in essential hypertension: Are connective tissue growth factor and transforming growth factor involved?. Kidney Int. 2006;69(7):1104–1105
- Diamond JR, Karnovsky MJ. Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int. 1988;33(5):917–924
- Terada Y, Ueda S, Hamada K, et al. Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1. Clin Exp Nephrol. 2012;16(1):81–88
- de Las HN, Ruiz-Ortega M, Ruperez M, et al. Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II. J Renin Angiotensin Aldosterone Syst. 2006;7(4):192–200
- Endlich N, Endlich K. Stretch, tension and adhesion – Adaptive mechanisms of the actin cytoskeleton in podocytes. Eur J Cell Biol. 2006;85(3–4):229–234
- Li Y, Kang YS, Dai C, et al. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol. 2008;172(2):299–308
- Barisoni L. Podocyte biology in segmental sclerosis and progressive glomerular injury. Adv Chronic Kidney Dis. 2012;19(2):76–83
- Reiser J, Sever S. Podocyte biology and pathogenesis of kidney disease. Annu Rev Med. 2013;64:357–366
- Kriz W, Lehir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int. 2005;67(2):404–419
- Li K, Wang J, Yin X, et al. Alteration of podocyte protein expression and localization in the early stage of various hemodynamic conditions. Int J Mol Sci. 2013;14(3):5998–6011
- Kretzler M, Koeppen-Hagemann I, Kriz W. Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised-desoxycorticosterone hypertensive rat. Virchows Arch. 1994;425(2):181–193
- Kirsch T, Kaufeld J, Korstanje R, et al. Knockdown of the hypertension-associated gene NOSTRIN alters glomerular barrier function in zebrafish (Danio rerio). Hypertension. 2013;62(4):726–730
- Berman S, Abu HR, Efrati S. Mesangial cells are responsible for orchestrating the renal podocytes injury in the context of malignant hypertension. Nephrology (Carlton). 2013;18(4):292–298
- Lewis EJ, Hunsicker LG, Bain RP, et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993;329(20):1456–1462
- Liebau MC, Lang D, Bohm J, et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol. 2006;290(3):F710–F719
- Nagase M, Shibata S, Yoshida S, et al. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension. 2006;47(6):1084–1093
- Durvasula RV, Petermann AT, Hiromura K, et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int. 2004;65(1):30–39
- Jia J, Ding G, Zhu J, et al. Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis. Am J Nephrol. 2008;28(3):500–507
- Patrakka J, Tryggvason K. New insights into the role of podocytes in proteinuria. Nat Rev Nephrol. 2009;5(8):463–468
- Roestenberg P, van Nieuwenhoven FA, Joles JA, et al. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice. Am J Physiol Renal Physiol. 2006;290(6):F1344–F1354
- Forbes JM, Fukami K, Cooper ME. Diabetic nephropathy: Where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes. 2007;115(2):69–84
- Yokoi H, Mukoyama M, Mori K, et al. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int. 2008;73(4):446–455
- Li JJ, Kwak SJ, Jung DS, et al. Podocyte biology in diabetic nephropathy. Kidney Int Suppl. 2007;106:S36–S42
- Kimura K, Suzuki N, Ohba S, et al. Hypertensive glomerular damage as revealed by the expression of alpha-smooth muscle actin and non-muscle myosin. Kidney Int Suppl. 1996;55:S169–S172
- Le Jemtel TH, Lambert F, Levitsky DO, et al. Age-related changes in sarcoplasmic reticulum Ca(2+)-ATPase and alpha-smooth muscle actin gene expression in aortas of normotensive and spontaneously hypertensive rats. Circ Res. 1993;72(2):341–348
- Liu X, Lu L, Tao BB, et al. Amelioration of glomerulosclerosis with all-trans retinoic acid is linked to decreased plasminogen activator inhibitor-1 and alpha-smooth muscle actin. Acta Pharmacol Sin. 2011;32(1):70–78
- Dai HY, Zheng M, Lv LL, et al. The roles of connective tissue growth factor and integrin-linked kinase in high glucose-induced phenotypic alterations of podocytes. J Cell Biochem. 2012;113(1):293–301
- Tuncdemir M, Ozturk M. The effects of angiotensin-II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin-induced diabetic nephropathy. Acta Histochem. 2011;113(8):826–832
- Ding G, Reddy K, Kapasi AA, et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol. 2002;283(1):F173–F180
- Barisoni L, Schnaper HW, Kopp JB. Advances in the biology and genetics of the podocytopathies: Implications for diagnosis and therapy. Arch Pathol Lab Med. 2009;133(2):201–216